Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abou Family ResidenceXTAE:ABOU -1.73%23 3-Year RORE % is 0.00 as of . 20. GuruFocus rates XTAE:ABOU with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 773 Medical Devices & Instruments companies, Abou Family Residence ranks worse than 129365.98% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Abou Family Residence does not have enough data to calculate 3-Year RORE %.
Abou Family Residence (XTAE:ABOU) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Abou Family Residence 3-Year RORE % Related Terms
Abou Family Residence 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Abou Family Residence's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abou Family Residence 3-Year RORE % Chart
Abou Family Residence Annual Data
Trend
3-Year RORE %
Abou Family Residence Semi-Annual Data
3-Year RORE %
XTAE:ABOU vs ABT, SYK, MDT: 3-Year RORE % Comparison
For the Medical Devices subindustry, Abou Family Residence's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abou Family Residence 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abou Family Residence's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Abou Family Residence's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in . 20 and 3-year before.
Abou Family Residence (XTAE:ABOU) has a 3-Year RORE % of 0.00 as of . 20. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Abou Family Residence and its competitors. According to the industry distribution chart, Abou Family Residence ranks #999999 out of 773 companies in the Medical Devices & Instruments industry.
Is Abou Family Residence's 3-Year RORE % too high?
Abou Family Residence's current 3-Year RORE % is 0.00. Based on the distribution chart, Abou Family Residence ranks #999999 out of 773 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abou Family Residence has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Abou Family Residence's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Abou Family Residence ranks #999999 out of 773 companies for 3-Year RORE %. This places Abou Family Residence in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Abou Family Residence and its competitors. Abou Family Residence's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abou Family Residence stock overvalued right now?
Abou Family Residence (XTAE:ABOU) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Abou Family Residence's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Abou Family Residence (XTAE:ABOU), the current 3-Year RORE % is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Abou Family Residence Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.
23GF Score
Get the complete analysis for XTAE:ABOU
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ABOU has been successfully added to your 
